Search Results - "Zurkova, Monika"

Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry by Zurkova, Monika, Kriegova, Eva, Kolek, Vitezslav, Lostakova, Vladimira, Sterclova, Martina, Bartos, Vladimir, Doubkova, Martina, Binkova, Ilona, Svoboda, Michal, Strenkova, Jana, Janotova, Marketa, Plackova, Martina, Lacina, Ladislav, Rihak, Vladimir, Petrik, Frantisek, Lisa, Pavlina, Bittenglova, Radka, Tyl, Richard, Ondrejka, Gustav, Suldova, Hana, Lnenicka, Jaroslav, Psikalova, Jana, Snizek, Tomas, Homolka, Jiri, Kralova, Renata, Kervitzer, Jan, Vasakova, Martina

“…Pirfenidone, an antifibrotic drug, slows-down the disease progression in idiopathic pulmonary fibrosis (IPF) over 12 months, however limited data on the…”
Get full text

Adherence to the ISHLT Protocol for the Referral of Patients with Idiopathic Pulmonary Fibrosis to the Transplantation Center among of Czech Centers for Interstitial Lung Diseases by Sterclova, Martina, Doubkova, Martina, Sykorova, Lubica, Bartos, Vladimir, Zurkova, Monika, Lostakova, Vladimira, Mokosova, Radka, Plackova, Martina, Lacina, Ladislav, Cimrova, Michaela, Bittenglova, Radka, Lisa, Pavlina, Musilova, Pavla, Dolezal, Daniel, Psikalova, Jana, Ovesna, Petra, Koziar Vasakova, Martina

“…There are limited data on referral rates and the number of patients with idiopathic pulmonary fibrosis (IPF) who are eligible for lung transplantation. The aim…”
Get full text

Correlation Network Analysis Reveals Relationships between MicroRNAs, Transcription Factor T-bet, and Deregulated Cytokine/Chemokine-Receptor Network in Pulmonary Sarcoidosis by Kriegova, Eva, Gajdos, Petr, Zurkova, Monika, Kudelka, Milos, Novosad, Tomas, Fillerova, Regina, Dyskova, Tereza, Kolek, Vitezslav

“…Sarcoidosis is an inflammatory granulomatous disease with unknown etiology driven by cytokines and chemokines. There is limited information regarding the…”
Get full text

DSP rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: a pilot study by Doubkova, Martina, Kriegova, Eva, Littnerova, Simona, Schneiderova, Petra, Sterclova, Martina, Bartos, Vladimir, Plackova, Martina, Zurkova, Monika, Bittenglova, Radka, Lostaková, Vladimira, Siskova, Lenka, Lisa, Pavlina, Suldova, Hana, Doubek, Michael, Psikalova, Jana, Snizek, Tomas, Musilova, Pavlina, Vasakova, Martina

“…Background: The antifibrotic drugs nintedanib and pirfenidone are used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the association of…”
Get full text

Interleukin-1 Gene Cluster Polymorphisms in Sarcoidosis and Idiopathic Pulmonary Fibrosis by HUTYROVA, BEATA, PANTELIDIS, PANAGIOTIS, DRABEK, JIRI, ZURKOVA, MONIKA, KOLEK, VITEZSLAV, LENHART, KAREL, WELSH, KENNETH I, DU BOIS, ROLAND M, PETREK, MARTIN

“…Members of the interleukin-1 (IL-1) family are implicated in the pathogenesis of sarcoidosis and idiopathic pulmonary fibrosis (IPF). We have, therefore,…”
Get full text

Short- and long-term clinical outcomes of nintedanib therapy in IPF patients with different phenotypes: A retrospective registry-based study by Koziar Vašáková, Martina, Gregor, Jakub, Mogulkoc, Nesrin, Kramer, Mordechai R., Lewandowska, Katarzyna, Šterclová, Martina, Müller, Veronika, Slivka, Róbert, Studnicka, Michael, Plačková, Martina, Žurková, Monika, Tekavec-Trkanjec, Jasna, Doubková, Martina, Ovesná, Petra

“…There is a lack of data on the long-term effect of nintedanib on survival in specific groups of idiopathic pulmonary fibrosis (IPF) patients with different…”
Get full text

The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry by Gregor, Jakub, Adir, Yochai, Šterclová, Martina, Mogulkoc, Nesrin, Kramer, Mordechai R., Doubková, Martina, Plačková, Martina, Müller, Veronika, Studnicka, Michael, Žurková, Monika, Lacina, Ladislav, Lewandowska, Katarzyna, Bartoš, Vladimír, Ovesná, Petra, Májek, Ondřej, Koziar Vašáková, Martina

“…[Display omitted] Most patients with idiopathic pulmonary fibrosis (IPF) treated with antifibrotics (AF) have progressive disease despite treatment. A switch…”
Get full text

EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis by Doubková, Martina, Švancara, Jan, Svoboda, Michal, Šterclová, Martina, Bartoš, Vladimír, Plačková, Martina, Lacina, Ladislav, Žurková, Monika, Binková, Ilona, Bittenglová, Radka, Lošťáková, Vladimíra, Merta, Zdeněk, Šišková, Lenka, Tyl, Richard, Lisá, Pavlína, Šuldová, Hana, Petřík, František, Pšikalová, Jana, Řihák, Vladimír, Snížek, Tomáš, Reiterer, Pavel, Homolka, Jiří, Musilová, Pavlína, Lněnička, Jaroslav, Palúch, Peter, Hrdina, Roman, Králová, Renata, Hortvíková, Hana, Strenková, Jana, Vašáková, Martina

“…Prognostic factors of idiopathic pulmonary fibrosis (IPF) currently recognized include changes in vital capacity and radiologic findings. However, most of the…”
Get more information

Sex transition from female to male as a risk factor for sleep-disordered breathing by Genzor, Samuel, Prasko, Jan, Mizera, Jan, Kufa, Jiri, Zurkova, Monika, Jakubec, Petr, Vykopal, Martin, Vanek, Jakub

“…The female-to-male (FtM) sex transition requires lifelong supplementation with male sex hormones, resulting in high prevalence of weight gain, fat…”
Get full text

The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry by Štefániková, Marianna, Doubková, Martina, Ovesná, Petra, Šterclová, Martina, Lacina, Ladislav, Žurková, Monika, Plačková, Martina, Bartoš, Vladimír, Janíčková, Ivana, Bittenglová, Radka, Anton, Jan, Sýkorová, Ľubica, Lošťáková, Vladimíra, Musilová, Pavlína, Šuldová, Hana, Mokošová, Radka, Didyk, Jurij, Šišáková, Lenka, Lisá, Pavlína, Lněnička, Jaroslav, Dařičková, Hana, Doležel, Daniel, Pšikalová, Jana, Tyl, Richard, Králová, Renata, Vašáková, Martina Koziar

“…The antifibrotic drug nintedanib is used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the effect of nintedanib on antifibrotic…”
Get full text

Physical activity coaching in patients with interstitial lung diseases: A randomized controlled trial by Breuls, Sofie, Zlamalova, Tamara, Raisova, Katerina, Blondeel, Astrid, Wuyts, Marieke, Dvoracek, Martin, Zurkova, Monika, Yserbyt, Jonas, Janssens, Wim, Wuyts, Wim, Troosters, Thierry, Demeyer, Heleen

“…Physical activity is reduced in patients with interstitial lung disease (ILD) and physical inactivity is related to poor health outcomes. We investigated the…”
Get full text

Comparison of lymphocyte immune phenotypes in bronchoalveolar lavage of non-smoking patients with sarcoidosis and other interstitial lung diseases by Novosadova, Eva, Navratilova, Zdenka, Ordeltova, Marta, Zurkova, Monika, Zatloukal, Jaromir, Kolek, Vitezslav, Petrek, Martin

“…Bronchoalveolar lavage (BAL) as complementary method is still used as ancillary tool in diagnosis of interstitial lung diseases. Tobacco smoking has been…”
Get full text

Extrapulmonary involvement in patients with sarcoidosis and comparison of routine laboratory and clinical data to pulmonary involvement by Zurkova, Monika, Kolek, Vitezslav, Tomankova, Tereza, Kriegova, Eva

“…Patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis differ in symptom severity and health status impairment. To date there is no information…”
Get full text

Sarcoidosis of female reproductive organs in a postmenopausal woman: a case report and review of the literature: is there a potential for hormone therapy? by Zurkova, Monika, Turkova, Marie, Tichy, Tomas, Pilka, Radovan, Kolek, Vitezslav, Kriegova, Eva

“…OBJECTIVESarcoidosis is a multisystem inflammatory disorder of unknown cause that affects multiple organs. To date, only isolated cases of extrapulmonary…”
Get full text

rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: a pilot study by Martina Doubkova, Eva Kriegova, Simona Littnerova, Petra Schneiderova, Martina Sterclova, Vladimir Bartos, Martina Plackova, Monika Zurkova, Radka Bittenglova, Vladimira Lostaková, Lenka Siskova, Pavlina Lisa, Hana Suldova, Michael Doubek, Jana Psikalova, Tomas Snizek, Pavlina Musilova, Martina Vasakova

“…Background: The antifibrotic drugs nintedanib and pirfenidone are used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the association of…”
Get full text

The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis by Tran, Tanja, Šterclová, Martina, Mogulkoc, Nesrin, Lewandowska, Katarzyna, Müller, Veronika, Hájková, Marta, Kramer, Mordechai R, Jovanović, Dragana, Tekavec-Trkanjec, Jasna, Studnicka, Michael, Stoeva, Natalia, Hejduk, Karel, Dušek, Ladislav, Suissa, Samy, Vašáková, Martina

“…Several registries of idiopathic pulmonary fibrosis (IPF) have been established to better understand its natural history, though their size and duration of…”
Get full text

Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study by Jovanovic, Dragana M, Šterclová, Martina, Mogulkoc, Nesrin, Lewandowska, Katarzyna, Müller, Veronika, Hájková, Marta, Studnicka, Michael, Tekavec-Trkanjec, Jasna, Littnerová, Simona, Vašáková, Martina

“…Patients with idiopathic pulmonary fibrosis (IPF) frequently have multiple comorbidities, which may influence survival but go under-recognised in clinical…”
Get full text

Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry by Doubková, Martina, Uher, Michal, Bartoš, Vladimír, Šterclová, Martina, Lacina, Ladislav, Lošťáková, Vladimíra, Binková, Ilona, Plačková, Martina, Žurková, Monika, Bittenglová, Radka, Pšikalová, Jana, Šišková, Lenka, Lisá, Pavlína, Petřík, František, Polák, Jaroslav, Řihák, Vladimír, Skřičková, Jana, Vašáková, Martina

“…Idiopathic pulmonary fibrosis (IPF) is a rare, progressive and usually fatal form of idiopathic interstitial pneumonia. IPF is characterized by failure of…”
Get more information